The acquisition further strengthens M3’s European presence, with Pharma-Insight’s dedicated German call centre, plus coverage in Germany, the UK, France, Denmark, Netherlands, Norway, Austria, Italy, Poland, Switzerland, Spain and the Czech Republic, alongside capabilities in the US, Canada, Brazil, China, Japan and South Korea. 

Founded in 2003 by the Baus family, and headquartered in Hilden, Germany, Pharma-Insight has a portfolio of market research services covering the life sciences industry. This includes a dedicated healthcare panel, the addition of which further strengthens M3’s provider panel.

Pharma-Insight continues under the stewardship of co-founder Gabi Baus and the team, with Guido Baus supporting the integration of the company into M3 as a consultant. The acquisition follows the recent purchase of Australia’s Ekas in December last year and is describe as evidence of M3’s strategy for aggressive global growth.

“We’re delighted to welcome Pharma-Insight to the M3 family,” said M3 Global Research’s chief executive, Anton Richter. “Europe remains a strong area of focus for us and Germany is an important audience for us and our clients.

“The Pharma-Insight team’s wealth of experience and deep knowledge of the healthcare space is a perfect fit with M3’s global proposition.

“This acquisition represents our commitment to continuous investment in our core markets, and we look forward to being able to leverage a dedicated physical presence in Germany for the benefit of our clients.”